Efficacy of gonadotropin-releasing hormone agonist addition for luteal phase support in women with repeated implantation failure undergoing intracytoplasmic sperm injection cycles - intracytoplasmic sperm injection cycles .Gonadotropin releasing hormone.

Trial Profile

Efficacy of gonadotropin-releasing hormone agonist addition for luteal phase support in women with repeated implantation failure undergoing intracytoplasmic sperm injection cycles - intracytoplasmic sperm injection cycles .Gonadotropin releasing hormone.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs Triptorelin (Primary)
  • Indications Female infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jan 2014 According to the Iranian Registry of Clinical Trials, Planned End Date changed from 22 Dec 2012 to 22 Dec 2013.
    • 20 Jan 2014 According to the Iranian Registry of Clinical Trials, Status changed from recruiting to active, no longer recruiting.
    • 15 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top